LandBridge Co. LLC(LB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LB LandBridge Co. LLC

Post-Mkt 06-18 18:14:18 EDT

63.95

+0.45

+0.71%

盘后63.95

+0.000.00%

16:10 EDT

High64.25	Low62.35	Vol277.25K
Open63.70	D1 Closing63.50	Amplitude2.99%
Mkt Cap4.93B	Tradable Cap3.65B	Total Shares77.02M
T/O17.53M	T/O Rate0.49%	Tradable Shares57.04M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LB","market":"US","secType":"STK","nameCN":"LandBridge Co. LLC","latestPrice":63.95,"timestamp":1781812800000,"preClose":63.5,"halted":0,"volume":277251,"hourTrading":{"tag":"盘后","latestPrice":63.95,"preClose":63.95,"latestTime":"16:10 EDT","volume":75,"amount":4796.25,"timestamp":1781813405336,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0070866141732283915,"floatShares":57044797,"shares":77017000,"eps":0.97,"marketStatus":"Post-Mkt","change":0.45,"latestTime":"06-18 18:14:18 EDT","open":63.7,"high":64.25,"low":62.35,"amount":17532020,"amplitude":0.029921,"askPrice":75.04,"askSize":100,"bidPrice":64,"bidSize":50,"shortable":3,"etf":0,"ttmEps":0.97,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1781827200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1719547200000,"exchange":"NYSE","adjPreClose":63.5,"dividendRate":0.006568,"preHourTrading":{"tag":"盘前","latestPrice":63.5562,"preClose":63.5,"latestTime":"08:53 EDT","volume":1109,"amount":69898.436823,"timestamp":1781787219731,"change":0.0562,"changeRate":0.000885,"amplitude":0.019783},"postHourTrading":{"tag":"盘后","latestPrice":63.95,"preClose":63.95,"latestTime":"16:10 EDT","volume":75,"amount":4796.25,"timestamp":1781813405336,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.928366,"impliedVol":0.5503,"impliedVolPercentile":0.2231},"requestUrl":"/m/hq/s/LB/tweets","defaultTab":"tweets","newsList":[{"id":"2643078157","title":"Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2643078157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643078157?lang=en_us&edition=fundamental","pubTime":"2026-06-16 06:30","pubTimestamp":1781562609,"startTime":"0","endTime":"0","summary":"Clear Street keeps a Buy rating and a $45 price target on LB Pharmaceuticals (LBRX). The firm contends that Neumora Therapeutics (NMRA) Phase 3 KOA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clear-street-says-neumora-failed-trial-does-not-impact-lb-pharmaceuticals-lb-102-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clear-street-says-neumora-failed-trial-does-not-impact-lb-pharmaceuticals-lb-102-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","NMRA","BK4233","LB","LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643646206","title":"BRIEF-Landbridge Forms Special Committee To Evaluate Conversion To Texas Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2643646206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643646206?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:10","pubTimestamp":1781529018,"startTime":"0","endTime":"0","summary":"BRIEF-Landbridge Forms Special Committee To Evaluate Conversion To Texas CorporationJune 15 (Reuters) - LandBridge Co LLC LB.N:LANDBRIDGE CO - FORMS SPECIAL COMMITTEE TO EVALUATE CONVERSION TO TEXAS C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nFWN42N0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4213","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205664","title":"LandBridge forms special committee to evaluate potential corporate conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205664?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:36","pubTimestamp":1781527009,"startTime":"0","endTime":"0","summary":"LandBridge (LB) Company announced that its board of directors has formed a special committee of independent directors to evaluate a potential conve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/landbridge-forms-special-committee-to-evaluate-potential-corporate-conversion-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/landbridge-forms-special-committee-to-evaluate-potential-corporate-conversion-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LB","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643817205","title":"LandBridge forms committee to weigh conversion to Texas corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2643817205","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643817205?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526647,"startTime":"0","endTime":"0","summary":"LandBridge formed a special committee of independent directors to assess converting from a Delaware LLC to a Texas corporation.Review targets potential eligibility for major equity indexes that limit membership to corporations, including S&P, Russell, and CRSP.Index inclusion could expand the investor base, lift trading liquidity, and raise market visibility, supporting growth financing and long-term value.Committee will weigh governance and tax implications; no decision or completion timeline disclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Landbridge Company LLC published the original content used to generate this news brief via Business Wire  on June 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDLcdL4fW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LB","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643221259","title":"LandBridge (LB) Stock After Higher 2026 EBITDA Outlook Is The Valuation Discount Still There","url":"https://stock-news.laohu8.com/highlight/detail?id=2643221259","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643221259?lang=en_us&edition=fundamental","pubTime":"2026-06-13 21:25","pubTimestamp":1781357153,"startTime":"0","endTime":"0","summary":"Why LandBridge (LB) Is Back on Investors’ Radar\nLandBridge (LB) has drawn fresh attention after management lifted its full-year 2026 adjusted EBITDA outlook to a range of $210 million to $230 million, citing a more supportive macro backdrop.\nSee our latest analysis for LandBridge.\nDespite a 1-day share price return of 2.76% taking LandBridge to $69.29, the stock is still down 7.35% over 90 days and its 1-year total shareholder return has declined 3.78%. This suggests momentum has cooled, even...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/landbridge-lb-stock-after-higher-2026-ebitda-outlook-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/landbridge-lb-stock-after-higher-2026-ebitda-outlook-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4213","BK4233","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642349060","title":"LB Pharmaceuticals Stockholders Approve Directors and Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2642349060","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642349060?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:57","pubTimestamp":1781038629,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. ( ($LBRX) ) has shared an announcement. LB Pharmaceuticals, Inc. reported the results of its 2026 Annual Meeting of Stockh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lb-pharmaceuticals-stockholders-approve-directors-and-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lb-pharmaceuticals-stockholders-approve-directors-and-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX","BK4213","BK4233","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642435705","title":"H.C. Wainwright Sticks to Their Buy Rating for LB Pharmaceuticals, Inc. (LBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642435705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642435705?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:35","pubTimestamp":1780940148,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on LB Pharmaceuticals, Inc., with a price target of $45.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-lb-pharmaceuticals-inc-lbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-lb-pharmaceuticals-inc-lbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614803","title":"LandBridge price target lowered to $84 from $85 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614803?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:10","pubTimestamp":1780006212,"startTime":"0","endTime":"0","summary":"Goldman Sachs lowered the firm’s price target on LandBridge (LB) to $84 from $85 and keeps a Buy rating on the shares. The firm is refreshing its m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/landbridge-price-target-lowered-to-84-from-85-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/landbridge-price-target-lowered-to-84-from-85-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3B42.SGD","LU2237443622.USD","LU2471134879.HKD","LU2750360997.AUD","BK4552","IE0004091025.USD","LU0345770308.USD","LU1868836591.USD","BK4213","LU0868494708.USD","LU0345770993.USD","BK4550","BK4533","LU0251142724.SGD","LU2237443549.SGD","GSX","LU1868836914.USD","BK4233","LU0106831901.USD","LU0742534661.SGD","IE0002270589.USD","LU2237443978.SGD","LU2237443895.HKD","IE0034235188.USD","BK4588","LU2237438978.USD","LU2471134952.CNY","LU1868836757.USD","LU2750360641.GBP","LU2237443465.HKD","BK4127","IE0004086264.USD","LB","LU1668664300.SGD","LU1791807156.HKD","LU1804176565.USD","LU0251131958.USD","BK4585","IE00BSNM7G36.USD","LU1868837300.USD","LU1894683264.USD","BK4504","LU1894683348.USD","LU0048573561.USD","IE00B19Z3581.USD","IE00BFXG1179.USD","LU2237443382.USD","BK4516","LU0868494617.USD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639616388","title":"LB Pharmaceuticals to Participate in Upcoming June Investor Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2639616388","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639616388?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:05","pubTimestamp":1779998700,"startTime":"0","endTime":"0","summary":"NEW YORK, May  28, 2026  (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3303247/0/en/LB-Pharmaceuticals-to-Participate-in-Upcoming-June-Investor-Events.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LB","BK4213","LBRX","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638523876","title":"LB Pharmaceuticals initiated with a Buy at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2638523876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638523876?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:47","pubTimestamp":1779828442,"startTime":"0","endTime":"0","summary":"Clear Street analyst Kaveri Pohlman initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $45 price target The firm is citing its “...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4233","LBRX","LB","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638951542","title":"LB Pharmaceuticals: Buy Rating Reiterated, $45 Price Target Maintained on LB-102 Late-Stage Pipeline and Multi-Billion-Dollar Sales Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2638951542","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638951542?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:35","pubTimestamp":1779791723,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on LB Pharmaceuticals, Inc. today and set a price target of $45.00. Ram Selvaraju has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lb-pharmaceuticals-buy-rating-reiterated-45-price-target-maintained-on-lb-102-late-stage-pipeline-and-multi-billion-dollar-sales-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lb-pharmaceuticals-buy-rating-reiterated-45-price-target-maintained-on-lb-102-late-stage-pipeline-and-multi-billion-dollar-sales-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX","SSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637290198","title":"A Look At LandBridge (LB) Valuation As Earnings Growth And M&A Plans Draw Investor Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2637290198","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637290198?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:23","pubTimestamp":1779287033,"startTime":"0","endTime":"0","summary":"LandBridge earnings and M&A priorities draw investor attention\nLandBridge (LB) has drawn fresh attention after first quarter 2026 results showed revenue of $51.01 million and net income of $8.72 million, alongside management’s focus on accretive acquisitions and expanding fee surface ownership.\nSee our latest analysis for LandBridge.\nFollowing the earnings release and comments on disciplined M&A, LandBridge’s share price has shown strong momentum, with a 1-day share price return of 4.66% and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/a-look-at-landbridge-lb-valuation-as-earnings-growth-and-ma","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/a-look-at-landbridge-lb-valuation-as-earnings-growth-and-ma","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636014748","title":"LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636014748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636014748?lang=en_us&edition=fundamental","pubTime":"2026-05-18 07:40","pubTimestamp":1779061205,"startTime":"0","endTime":"0","summary":"Roth Capital raised the firm’s price target on LB Pharmaceuticals (LBRX) to $37 from $31 and keeps a Buy rating on the shares post the Q1 report. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-price-target-raised-to-37-from-31-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-price-target-raised-to-37-from-31-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635499907","title":"LandBridge's (NYSE:LB) Earnings May Just Be The Starting Point","url":"https://stock-news.laohu8.com/highlight/detail?id=2635499907","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635499907?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:17","pubTimestamp":1778768226,"startTime":"0","endTime":"0","summary":"LandBridge Company LLC ( NYSE:LB ) just reported healthy earnings but the stock price didn't move much. We think that...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/landbridges-nyselb-earnings-may-just-be-the-starting-point","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/landbridges-nyselb-earnings-may-just-be-the-starting-point","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LB","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635252212","title":"LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635252212","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635252212?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:46","pubTimestamp":1778622391,"startTime":"0","endTime":"0","summary":"“With multiple clinical trials ongoing, our focus is on execution to support several clinical readouts over the next three years that have the pote...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-reports-q1-eps-67c-consensus-67c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-reports-q1-eps-67c-consensus-67c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223322","title":"LB Pharmaceuticals Q1 EPS $(0.67) Beats $(0.75) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223322","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223322?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:06","pubTimestamp":1778620008,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (NASDAQ:LBRX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 95.47 percent increase over losses of $(14.79) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52508924/lb-pharmaceuticals-q1-eps-0-67-beats-0-75-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635237247","title":"Press Release: LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635237247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635237247?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"Initiated two late-stage clinical trials of LB-102: the pivotal Phase 3 NOVA-2 trial in schizophrenia and the Phase 2 ILLUMINATE-1 trial in bipolar depression. Published results from the Phase 2 NOVA-1 trial of LB-102 in schizophrenia in The Journal of the American Medical Association  Psychiatry. Expanded pipeline following $100 million private placement with plans to initiate a Phase 2 trial of LB-102 in adjunctive treatment of major depressive disorder  in early 2027. Cash, cash equivalents, and marketable securities of $365.6 million as of March 31, 2026 expected to fund operations into Q2 2029, through multiple clinical milestones","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4007","BK4213","LBRX","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633238450","title":"LandBridge Price Target Raised to $66.00/Share From $65.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2633238450","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633238450?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:12","pubTimestamp":1778253120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2026 11:12 ET (15:12 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","LB","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116021290","title":"Stock Track | LandBridge Co. LLC Plummets 5.35% Intraday After Missing Q1 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1116021290","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116021290?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:21","pubTimestamp":1778178094,"startTime":"0","endTime":"0","summary":"LandBridge Co. LLC (LB) shares plummeted 5.35% during intraday trading on Thursday.The sharp decline followed the company's release of its first-quarter financial results, which fell short of analyst...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151940283","title":"Stock Track | LandBridge Plunges 5.30% in Pre-market After Missing Q1 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1151940283","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151940283?lang=en_us&edition=fundamental","pubTime":"2026-05-07 17:36","pubTimestamp":1778146596,"startTime":"0","endTime":"0","summary":"LandBridge Co. LLC (LB) shares plummeted 5.30% during pre-market trading on Thursday, following the release of the company's first-quarter financial results.The decline comes after LandBridge...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["LB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.landbridgeco.com","stockEarnings":[{"period":"1week","weight":-0.0358},{"period":"1month","weight":-0.1217},{"period":"3month","weight":-0.1063},{"period":"6month","weight":0.2098},{"period":"1year","weight":-0.0983},{"period":"ytd","weight":0.2962}],"compareEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.123},{"period":"6month","weight":0.0887},{"period":"1year","weight":0.24},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"L Brands, Inc. operates as a specialty retailers of body care, home fragrance products, soaps, and sanitizers. The company sells its products under the Bath & Body Works, White Barn, C.O. Bigelow, and other brand names. It operates approximately 1,750 Bath & Body Works stores in the United States and Canada, as well as online at BathandBodyWorks.com. In addition, the company has approximately 295 stores in 30 other countries operating under franchise, license, and wholesale arrangements. L Brands, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.023575},{"month":2,"riseRate":0.641026,"avgChangeRate":0.037322},{"month":3,"riseRate":0.589744,"avgChangeRate":0.019442},{"month":4,"riseRate":0.615385,"avgChangeRate":0.03057},{"month":5,"riseRate":0.5,"avgChangeRate":0.032148},{"month":6,"riseRate":0.45,"avgChangeRate":-0.016926},{"month":7,"riseRate":0.475,"avgChangeRate":0.023341},{"month":8,"riseRate":0.425,"avgChangeRate":-0.017396},{"month":9,"riseRate":0.6,"avgChangeRate":0.004595},{"month":10,"riseRate":0.641026,"avgChangeRate":0.026823},{"month":11,"riseRate":0.641026,"avgChangeRate":0.029598},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.015843}],"exchange":"NYSE","name":"LandBridge Co. LLC","nameEN":"LandBridge Co. LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LandBridge Co. LLC(LB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LandBridge Co. LLC(LB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LandBridge Co. LLC,LB,LandBridge Co. LLC股票,LandBridge Co. LLC股票老虎,LandBridge Co. LLC股票老虎国际,LandBridge Co. LLC行情,LandBridge Co. LLC股票行情,LandBridge Co. LLC股价,LandBridge Co. LLC股市,LandBridge Co. LLC股票价格,LandBridge Co. LLC股票交易,LandBridge Co. LLC股票购买,LandBridge Co. LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LandBridge Co. LLC(LB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LandBridge Co. LLC(LB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction